| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 0 | 2.434.591 | 780.255 | 0 | - |
| Total Income - EUR | - | - | - | - | - | 0 | 2.438.775 | 784.839 | 0 | - |
| Total Expenses - EUR | - | - | - | - | - | 458 | 2.384.191 | 785.735 | 410 | - |
| Gross Profit/Loss - EUR | - | - | - | - | - | -458 | 54.584 | -896 | -410 | - |
| Net Profit/Loss - EUR | - | - | - | - | - | -458 | 44.073 | -1.064 | -410 | - |
| Employees | - | - | - | - | - | 1 | 1 | 1 | 0 | - |
Check the financial reports for the company - Alymed Flexy Prim S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 52 | 6.842 | 1.911 | 1.905 | - |
| Current Assets | - | - | - | - | - | 6 | 122.258 | 137.006 | 133.164 | - |
| Inventories | - | - | - | - | - | 0 | 24.175 | 1.402 | 1.398 | - |
| Receivables | - | - | - | - | - | 0 | 90.916 | 110.323 | 128.196 | - |
| Cash | - | - | - | - | - | 6 | 7.167 | 25.280 | 3.571 | - |
| Shareholders Funds | - | - | - | - | - | -376 | 52.807 | 51.906 | 51.506 | - |
| Social Capital | - | - | - | - | - | 83 | 9.178 | 9.206 | 9.178 | - |
| Debts | - | - | - | - | - | 433 | 54.057 | 87.010 | 83.564 | - |
| Income in Advance | - | - | - | - | - | 0 | 22.237 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4677 - 4677" | |||||||||
| CAEN Financial Year |
4677
|
|||||||||
Comments - Alymed Flexy Prim S.r.l.